参与肥胖症中瘦素敏感化的新机制
Veronica Pena-Leon1, Raquel Perez-Lois1, Maria Villalon1
1Grupo Fisiopatología Endocrina, Departamento de Endocrinología, Instituto de Investigación Sanitaria de Santiago de Compostela, Complexo Hospitalario Universitario de Santiago (CHUS/SERGAS), Santiago de Compostela, Travesía da Choupana s/n, 15706 Santiago de Compostela, Spain.
肥胖症中的勒素耐药性是一个主要的挑战. 本综述探讨了胃肠道激素和其他因素如何克服瘦素不反应,为代谢障碍提供新的治疗途径.
科学领域:
- 内分泌学 在内分泌学.
- 代谢研究研究 代谢研究
- 神经科学是一个神经科学.
背景情况:
- 脂肪细胞中的荷尔蒙 - - 丁,通过向大脑发出信号来调节身体的能量平衡.
- 肥胖通常会导致瘦素耐药性,即身体不再有效地对瘦素做出反应.
- 这种耐药性阻碍了针对代谢并发症的基于勒丁的治疗方法的开发.
研究的目的:
- 审查有关肥胖症中瘦素耐药性的当前知识.
- 为了探索瘦素和胃肠-大脑轴激素之间的相互作用.
- 讨论增强瘦素敏感性的新机制.
主要方法:
- 临床前和临床研究的文献综述.
- 对影响莱普信号传递的内分泌因素的分析.
- 研究导致勒素耐药性的分子机制.
主要成果:
- 肥胖症的特点是瘦素水平升高和瘦素作用受损.
- 胃肠道激素 (例如GLP-1,氨酸) 可以减轻瘦素抵抗.
- 蛋白质稳定,激酶和ER压力等因素也在瘦素敏感性中起作用.
结论:
- 了解勒素抵抗机制对于开发有效的肥胖治疗非常重要.
- 针对胃肠道-大脑轴的综合疗法显示出有前途.
- 需要新的策略来恢复肥胖个体的瘦素敏感性.
更多相关视频
05:45Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing
Published on: October 25, 2019
09:41Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
相关概念视频
Regulation of Food Intake
Obesity
Insulin: The Receptor and Signaling Pathways
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
